{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:47:01Z","timestamp":1784123221747,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.semarthrit.2020.06.012","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T19:29:11Z","timestamp":1593545351000},"page":"1150-1157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients"],"prefix":"10.1016","volume":"50","author":[{"given":"Giuseppe A.","family":"Ramirez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gerosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bellocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza M.","family":"Argolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Della Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Artusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene","family":"Nicolosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Caporali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica P.","family":"Bozzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2020.06.012_bib0001","doi-asserted-by":"crossref","unstructured":"Ciceri F, Beretta L, Scandroglio AM, Colombo S, Landoni G, Ruggeri A, et\u00a0al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. 2020.","DOI":"10.51893\/2020.2.pov2"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0002","doi-asserted-by":"crossref","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et\u00a0al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020.","DOI":"10.1056\/NEJMoa2002032"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0003","unstructured":"ISTAT-Istituto-Nazionale-di-Statistica-(Italian-national-institute-of-statistics). Population by Region 2020. http:\/\/dati.istat.it."},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0004","unstructured":"Protezione_Civile_Italiana_(Italian_national_emergency_agency). [COVID-19 Italia] COVID-19 Italy 2020. https:\/\/github.com\/pcm-dpc\/COVID-19."},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0005","unstructured":"Regione-Lombardia-(Government-of-the-Region-of-Lombardy). [Coronavirus in Lombardia, tutti gli aggiornamenti in diretta] Coronavirus in Lombardy, all live updates. 2020[cited 2020 27-APR-2020]; Available from:https:\/\/www.lombardianotizie.online\/coronavirus-casi-lombardia\/"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0006","unstructured":"Regione-Lombardia-(Government-of-the-Region-of-Lombardy). [DELIBERAZIONE N\u00b0 XI \/ 2986 Seduta del 23\/03\/2020] regional resolution XI \/ 2986 Session of the 23rdMarch 2020. 2020."},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0007","doi-asserted-by":"crossref","unstructured":"Rosenbaum L. Facing Covid-19 in Italy - ethics, logistics, and therapeutics on the epidemic's front line. N Engl J Med. 2020Mar 18.","DOI":"10.1056\/NEJMp2005492"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0008","first-page":"175","article-title":"COVID-19 in Italy: impact of containment measures and prevalence estimates of infection in the general population","volume":"91","author":"Signorelli","year":"2020","journal-title":"Acta Bio Med"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0009","article-title":"The COVID-19 infection in Italy: a statistical study of an abnormally severe disease","author":"De Natale","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol J"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.012_bib0011","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0012","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"105949","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0013","doi-asserted-by":"crossref","unstructured":"Molina JM, Delaugerre C, Goff J, Mela-Lima B, Ponscarme D, Goldwirt L, et\u00a0al. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7195369\/# Med Mal Infect. 2020:30085\u20138.","DOI":"10.1016\/j.medmal.2020.03.006"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0014","unstructured":"World-Health-Organization. Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts - Interim guidance 17 March 2020. 2020."},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0015","unstructured":"Societ\u00e0-Italiana-di-Malattie-Infettive-e-Tropicali-(SIMT-Italian-society-for-infectious-and-tropical-diseases). [Vademecum per la cura delle persone con malattia da COVID-19 Edizione 2.0, 13 marzo 2020] guidelines for the care of people with COVID-19 - version 2.0, 13th March 2020. 2020."},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108410","article-title":"Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients","author":"Sawalha","year":"2020","journal-title":"Clin Immunol."},{"issue":"22","key":"10.1016\/j.semarthrit.2020.06.012_bib0017","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.012_bib0018","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.1100450","article-title":"Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus","volume":"187","author":"Villanueva","year":"2011","journal-title":"Journal of immunology"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.06.012_bib0019","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2017.02.001","article-title":"Expanding the B cell-centric view of systemic lupus Erythematosus","volume":"38","author":"Morawski","year":"2017","journal-title":"Trends Immunol"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0020","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3389\/fimmu.2018.01088","article-title":"Aberrant T cell signaling and subsets in systemic lupus Erythematosus","volume":"9","author":"Katsuyama","year":"2018","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.06.012_bib0021","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/art.40180","article-title":"Peripheral Immunophenotyping identifies three subgroups based on T cell heterogeneity in lupus patients","volume":"69","author":"Kubo","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.012_bib0022","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat Med"},{"issue":"73","key":"10.1016\/j.semarthrit.2020.06.012_bib0023","doi-asserted-by":"crossref","first-page":"73ra20","DOI":"10.1126\/scitranslmed.3001201","article-title":"Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus","volume":"3","author":"Garcia-Romo","year":"2011","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.012_bib0024","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41591-020-0769-8","article-title":"Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus","volume":"26","author":"Kotliarov","year":"2020","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.06.012_bib0025","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1177\/0961203313493032","article-title":"Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies","volume":"22","author":"Danza","year":"2013","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.012_bib0026","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/BOR.0000000000000289","article-title":"How compelling are the data for Epstein-Barr virus being a trigger for systemic lupus and other autoimmune diseases?","volume":"28","author":"Draborg","year":"2016","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.06.012_bib0027","first-page":"1660","article-title":"Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes","volume":"38","author":"Perl","year":"1995","journal-title":"Correlation withAntinuclear Antibodies and HLA Class II Alleles. Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.012_bib0028","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrrheum.2009.235","article-title":"Therapy: hydroxychloroquine in SLE: old drug, new perspectives","volume":"6","author":"Dorner","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"6 Pt 2","key":"10.1016\/j.semarthrit.2020.06.012_bib0029","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/j.lpm.2014.03.007","article-title":"Hydroxychloroquine: a multifaceted treatment in lupus","volume":"43","author":"Costedoat-Chalumeau","year":"2014","journal-title":"Presse Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.012_bib0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0961203307086503","article-title":"Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival","volume":"17","author":"Siso","year":"2008","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.012_bib0031","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/ken121","article-title":"Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences","volume":"47","author":"Ruiz-Irastorza","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.06.012_bib0032","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3899\/jrheum.161351","article-title":"Longterm hydroxychloroquine therapy and low-dose aspirin may have an additive effectiveness in the primary prevention of cardiovascular events in patients with systemic lupus Erythematosus","volume":"44","author":"Fasano","year":"2017","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.06.012_bib0033","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0961203306071872","article-title":"Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus","volume":"15","author":"Ruiz-Irastorza","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0034","doi-asserted-by":"crossref","unstructured":"Joob B, Wiwanitkit VSLE, hydroxychloroquine and no SLE patients with covid-19: a comment. Ann Rheum Dis. 2020.","DOI":"10.1136\/annrheumdis-2020-217506"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0035","unstructured":"Mathian A, Mahevas M, Rohmer J, Roumier M, Cohen-Aubart F, Amador-Borrero B, et\u00a0al. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine. Ann Rheum Dis. 2020."},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0036","doi-asserted-by":"crossref","unstructured":"Gianfrancesco MA, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Mateus EF, et\u00a0al. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. Lancet Rheumatol. 2020.","DOI":"10.1016\/S2665-9913(20)30095-3"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0037","series-title":"In: European-Commission, ed. 0829\/14\/EN WP216","article-title":"European-Commission. Article 29 data protection working party (0829\/14\/EN WP216)","year":"2014"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0038","first-page":"9","article-title":"Practical issues in calculating the sample size for prevalence studies","volume":"1","author":"Naing","year":"2006","journal-title":"Arch. Orofac. Sci."},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0039","series-title":"[Epidemia COVID-19 aggiornamento nazionale 23 aprile 2020 \u2013 ore 16:00] COVID-19 epidemic - Nationwide update 23rd april 2020 at 16:00","article-title":"Task-force-COVID-19-del-Dipartimento-Malattie-Infettive-e-Servizio-di-Informatica-dell'Istituto-Superiore-di-Sanit\u00e0-(Task-force-COVID-19-of-the-department-of-infectious-diseases-and-the-department-of-informatics-of-the-italian-national-institute-of-health)","year":"2020"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.06.012_bib0040","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/acr.21948","article-title":"High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus","volume":"65","author":"Campos","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0041","doi-asserted-by":"crossref","first-page":"37817","DOI":"10.1038\/srep37817","article-title":"Effects of annual influenza vaccination on morbidity and mortality in patients with systemic Lupus Erythematosus: a nationwide cohort study","volume":"6","author":"Chang","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.06.012_bib0042","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/rheumatology\/kes391","article-title":"All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre","volume":"52","author":"Lee","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.06.012_bib0043","first-page":"1559","article-title":"Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort","volume":"19","author":"Petri","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0044","doi-asserted-by":"crossref","unstructured":"Favalli EG, Ingegnoli F, Cimaz R, Caporali R. What is the true incidence of COVID-19 in patients with rheumatic diseases?. Ann Rheum Dis. 2020.","DOI":"10.1136\/annrheumdis-2020-217615"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0045","doi-asserted-by":"crossref","unstructured":"Tomelleri A, Sartorelli S, Campochiaro C, Baldissera EM, Dagna L. Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey. Ann Rheum Dis. 2020.","DOI":"10.1136\/annrheumdis-2020-217600"},{"key":"10.1016\/j.semarthrit.2020.06.012_bib0046","series-title":"JAMA health forum; 2020","article-title":"Potential shortages of Hydroxychloroquine for patients with lupus during the coronavirus disease 2019 pandemic","author":"Mehta","year":"2020"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.012_bib0047","doi-asserted-by":"crossref","first-page":"rky003","DOI":"10.1093\/rap\/rky003","article-title":"Going viral in rheumatology: using social media to show that mechanistic research is relevant to patients with lupus and antiphospholipid syndrome","volume":"2","author":"McDonnell","year":"2018","journal-title":"Rheumatol Adv Pract"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:06:32Z","timestamp":1758733592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017220301943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0049017220301943"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.06.012","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}